CircRNA-FTO for regulating and controlling ADSCs osteogenic differentiation and tissue regeneration and application of circRNA-FTO
A technology for bone tissue regeneration and osteogenic differentiation, applied in DNA/RNA fragments, recombinant DNA technology, bone/connective tissue cells, etc., can solve problems that have not been reported
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0062] Example 1 Adipose stem cell biological characteristics
[0063] 1. Isolation and culture of human adipose-derived stem cells
[0064] Abdominal adipose tissue was collected during liposuction and stored in a 20mL sterile syringe for later use, and stored in ice packs. Adipose tissue was centrifuged in a 50mL centrifuge tube at 1000rpm / 5min to remove the lower liquid. Adipose tissue was digested with 0.2% type I collagenase at a ratio of 1:1 for 40 minutes on a shaker at 37°C. After standing still, it could be seen that it was divided into three layers. Remove the upper grease layer, fully shake and filter (200 mesh filter). Then centrifuge at 1000rmp / 5min for three times to remove the supernatant liquid, and the cell sediment therein can be seen. Pipette the cells evenly with cell culture medium. Cells were then seeded in culture dishes at a density of 5×105 / mL. The cells were then placed at 37°C, 5% CO 2 , 95% humidity incubator. Subcultured to the third generat...
Embodiment 2
[0069] Example 2 Circ RNA-FTO was screened out, and its cell localization and expression changes in osteogenesis induction
[0070] 1. The adipose-derived stem cells were induced into osteogenesis for 0d, 3d, 5d, and 7d, and RNA was extracted, and the expression trend of CircRNA-FTO at different times was detected by RT-q PCR.
[0071] Experimental results such as Figure 4 As shown, the expression of Circ RNA-FTO increased over time during osteogenic differentiation.
[0072] 2. Design and transfection of small interfering RNA sequences
[0073] Circ RNA-FTO sequence (circbase ID: hsa-circ-0005941) designed primers, primers were synthesized and purified by Shanghai Gemma Biotechnology Co., Ltd., designed small interfering RNA sequences to inhibit the expression of Circ RNA-FTO (because the FTO sequence is too large, It is extremely difficult to successfully construct an overexpression vector, so the present invention conducts a reverse research demonstration by inhibiting t...
Embodiment 3C
[0085] Example 3 Circ RNA-FTO regulates tissue regeneration of adipose stem cells in vivo
[0086] The human adipose stem cell complex was subcutaneously implanted into the back of nude mice, and its tissue formation ability was observed.
[0087] 1. Transfer siRNA and negative control (Negative control, NC) into hADSCs by lipofection method
[0088] Human adipose stem cells were cultivated by the tissue block method and enzyme digestion method, and the vigorously growing third-generation adipose stem cells were inoculated on a 60mm culture dish, and the culture components were α-MEM medium (containing 10% fetal bovine serum, 2mmol / L glutamine Amide, 100 U / ml penicillin, 100 μg / ml streptomycin). siRNA and negative control (Negative control, NC) were transferred into adipose-derived stem cells by lipofection method, and the experiment was divided into two groups: (1) siRNA-NC transfected adipose-derived stem cells group (2) siRNA-FTO transfected adipose-derived stem cells ste...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com